Leadership Overview
Medtronic has 10 executives leading key functions including corporate communications, financial strategy, sales operations, innovation development, and enterprise technology.
Focused on advancing global healthcare technology, Medtronic delivers life-saving medical devices and digital health solutions to improve patient outcomes across more than 150 countries worldwide.
Focused on advancing global healthcare technology, Medtronic delivers life-saving medical devices and digital health solutions to improve patient outcomes across more than 150 countries worldwide.
Leadership Roles at Medtronic
Sally Mollman - Communications Senior Principal & Generalist & Chief Executive Officer, Communications
Sally Mollman, the Communications Senior Principal & Generalist & Chief Executive Officer, Communications at Medtronic, directs all internal and external messaging strategies. Overseeing global brand reputation, the Chief Executive Officer, Communications ensures alignment between corporate initiatives and public health objectives. This leadership role involves managing complex stakeholder relationships across diverse international markets. By refining the narrative surrounding medical device innovation, Sally Mollman directly impacts the market perception of the company. The Chief Executive Officer, Communications maintains rigorous standards for transparency while supporting the broader mission of improving patient outcomes through advanced technology. Through consistent engagement with healthcare providers and regulatory bodies, the Chief Executive Officer, Communications secures the company's position as a leader in the medical technology sector. Mollman drives the strategic communication framework that supports the long-term growth and stability of the organization.

Anil Suneja - Chief Financial Officer
Anil Suneja, the Chief Financial Officer at Medtronic, manages the global financial health and capital allocation strategies. Overseeing fiscal planning, the Chief Financial Officer ensures the company maintains robust liquidity to fund research and development in cardiovascular and neuroscience sectors. This leadership role involves coordinating with the Board to optimize shareholder value while balancing investments in emerging medical therapies. By implementing rigorous cost-management protocols, Anil Suneja directly supports the operational efficiency required to scale manufacturing across 150 countries. The Chief Financial Officer monitors economic trends to mitigate risks associated with global supply chains and regulatory shifts. Through precise financial forecasting, the Chief Financial Officer enables the organization to pursue aggressive growth targets in chronic disease management. Suneja maintains the integrity of financial reporting systems, ensuring compliance with international standards while fostering sustainable investment in life-saving medical technologies.
Eric Lenard - Vice President and Chief Financial Officer, Innovation, Development and Quality
Eric Lenard, the Vice President and Chief Financial Officer, Innovation, Development and Quality at Medtronic, manages the financial oversight of the research and development pipeline. Overseeing the budget for quality assurance, the Vice President and Chief Financial Officer, Innovation, Development and Quality ensures that every new medical device meets stringent safety standards before market entry. This leadership role involves allocating capital to high-potential innovation projects that address chronic disease management. By optimizing the cost structure of the development lifecycle, Eric Lenard directly accelerates the time-to-market for new therapies. The Vice President and Chief Financial Officer, Innovation, Development and Quality collaborates with engineering teams to maintain the highest levels of product reliability. Through rigorous financial monitoring, the Vice President and Chief Financial Officer, Innovation, Development and Quality supports the company's commitment to clinical excellence. Lenard ensures that innovation investments align with the long-term strategic goals of the organization.
Derek Rood - Chief Financial Officer, Cardiac Diagnostics Services & Strategic Incubator & Director, Cardiac Rhythm Management
Derek Rood, the Chief Financial Officer, Cardiac Diagnostics Services & Strategic Incubator & Director, Cardiac Rhythm Management at Medtronic, directs the financial strategy for the cardiac diagnostics and rhythm management divisions. Overseeing the strategic incubator, the Chief Financial Officer, Cardiac Diagnostics Services & Strategic Incubator & Director, Cardiac Rhythm Management identifies and funds early-stage technologies that promise to revolutionize heart health. This leadership role involves managing the P&L for critical cardiovascular services to ensure profitability and growth. By integrating financial discipline with clinical innovation, Derek Rood directly impacts the success of the cardiac rhythm management portfolio. The Chief Financial Officer, Cardiac Diagnostics Services & Strategic Incubator & Director, Cardiac Rhythm Management coordinates with clinical teams to evaluate the market viability of new diagnostic tools. Through strategic resource allocation, the Chief Financial Officer, Cardiac Diagnostics Services & Strategic Incubator & Director, Cardiac Rhythm Management supports the expansion of cardiac care solutions globally. Rood drives the financial performance of these specialized units to maintain market leadership.
Ryan Steines - Chief Financial Officer, Cardiovascular Portfolio
Ryan Steines, the Chief Financial Officer, Cardiovascular Portfolio at Medtronic, manages the financial operations for the company's largest medical device segment. Overseeing revenue streams from cardiovascular therapies, the Chief Financial Officer, Cardiovascular Portfolio ensures that the business unit maintains a competitive edge in global markets. This leadership role involves analyzing market demand and adjusting financial models to support the production of advanced heart-related medical devices. By optimizing the cost of goods sold, Ryan Steines directly improves the margins of the cardiovascular division. The Chief Financial Officer, Cardiovascular Portfolio collaborates with regional leaders to drive growth in emerging markets while sustaining performance in established territories. Through detailed financial planning, the Chief Financial Officer, Cardiovascular Portfolio enables the organization to invest in next-generation cardiovascular technologies. Steines provides the financial oversight necessary to ensure that the cardiovascular portfolio continues to deliver life-saving solutions to patients worldwide while meeting corporate profitability targets.
Amanda Hawley - Chief of Staff To Vice President of Sales
Amanda Hawley, the Chief of Staff To Vice President of Sales at Medtronic, coordinates the strategic execution of sales initiatives across the global medical device portfolio. Overseeing operational workflows, the Chief of Staff To Vice President of Sales ensures that regional sales teams receive the necessary resources to meet clinical adoption targets. This leadership role involves bridging the gap between product development and market delivery to maximize the impact of cardiovascular and diabetes technologies. By streamlining communication channels, Amanda Hawley directly improves the efficiency of the sales organization. The Chief of Staff To Vice President of Sales facilitates cross-functional collaboration to address the specific needs of healthcare providers in diverse geographic regions. Through data-driven performance analysis, the Chief of Staff To Vice President of Sales identifies opportunities for market expansion and revenue growth. Hawley supports the Vice President of Sales in executing high-level commercial strategies that enhance patient access to critical medical therapies.
Kristina Erickson - Executive Assistant To Chief Human Resources Officer
Kristina Erickson, the Executive Assistant To Chief Human Resources Officer at Medtronic, manages the administrative and operational priorities for the human resources leadership team. Overseeing the scheduling and coordination of key talent initiatives, the Executive Assistant To Chief Human Resources Officer ensures that the HR function operates with maximum efficiency. This leadership role involves facilitating communication between the Chief Human Resources Officer and other executive leaders to support organizational culture and workforce development. By organizing complex projects related to employee engagement and talent acquisition, Kristina Erickson directly contributes to the company's ability to attract top-tier medical technology professionals. The Executive Assistant To Chief Human Resources Officer maintains the confidentiality and integrity of sensitive personnel data. Through proactive management of the Chief Human Resources Officer's agenda, the Executive Assistant To Chief Human Resources Officer enables the leadership team to focus on strategic human capital goals. Erickson supports the development of a high-performing workforce that drives the company's mission.
Carey Wheetley - Director, Chief of Staff and Portfolio Lead - Global P & C Information Technology
Carey Wheetley, the Director, Chief of Staff and Portfolio Lead - Global P & C Information Technology at Medtronic, directs the integration of information technology across the global portfolio. Overseeing the IT project roadmap, the Director, Chief of Staff and Portfolio Lead - Global P & C Information Technology ensures that digital infrastructure supports the company's manufacturing and diagnostic capabilities. This leadership role involves managing the portfolio of technology investments to improve operational agility. By aligning IT initiatives with business objectives, Carey Wheetley directly enhances the efficiency of global operations. The Director, Chief of Staff and Portfolio Lead - Global P & C Information Technology coordinates with cross-functional teams to implement secure and scalable digital solutions. Through rigorous oversight of technology projects, the Director, Chief of Staff and Portfolio Lead - Global P & C Information Technology ensures that the organization remains at the forefront of digital health innovation. Wheetley drives the digital transformation strategy that supports the company's global reach.
Gregory Hake - Program Director, Business & Cardiovascular Surgery Chief of Staff
Gregory Hake, the Program Director, Business & Cardiovascular Surgery Chief of Staff at Medtronic, manages the execution of complex programs within the cardiovascular surgery division. Overseeing the strategic alignment of surgical product lines, the Program Director, Business & Cardiovascular Surgery Chief of Staff ensures that clinical needs are met with precision. This leadership role involves coordinating between surgical teams and business units to streamline the delivery of medical devices. By managing the program lifecycle, Gregory Hake directly impacts the success of cardiovascular surgery initiatives. The Program Director, Business & Cardiovascular Surgery Chief of Staff facilitates communication to ensure that all stakeholders remain focused on patient outcomes. Through the implementation of structured program management, the Program Director, Business & Cardiovascular Surgery Chief of Staff optimizes the performance of the surgical portfolio. Hake drives the operational excellence required to maintain the company's status as a premier provider of cardiovascular surgical solutions in global markets.
Sue Delfidio - Senior Director, Enterprise AI Programs and Chief of Staff, AI Center of Excellence
Sue Delfidio, the Senior Director, Enterprise AI Programs and Chief of Staff, AI Center of Excellence at Medtronic, directs the implementation of artificial intelligence across the enterprise. Overseeing the AI Center of Excellence, the Senior Director, Enterprise AI Programs and Chief of Staff, AI Center of Excellence ensures that machine learning technologies are integrated into medical device development and diagnostic services. This leadership role involves managing the strategic roadmap for AI adoption to improve clinical decision-making. By fostering innovation in data analytics, Sue Delfidio directly enhances the company's ability to diagnose and treat chronic diseases. The Senior Director, Enterprise AI Programs and Chief of Staff, AI Center of Excellence coordinates with technical teams to deploy scalable AI solutions that support global healthcare providers. Through the strategic management of AI programs, the Senior Director, Enterprise AI Programs and Chief of Staff, AI Center of Excellence drives the digital evolution of the company's product portfolio. Delfidio ensures that AI initiatives align with the broader mission of improving patient outcomes.
Explore Leadership Teams in Manufacturing
Founded in 1948 and headquartered in Switzerland, Varian Medical Systems is a manufacturer of medical devices and software for the treatment of cancer and other medical conditions, utilizing radiotherapy, radiosurgery, proton therapy, and brachytherapy.
Company Leadership DH
ESTABLISHMENT LABS HOLDINGS INC. (NASDAQ:ESTA) is a global medical technology company dedicated to improving women’s health and wellness through the power of science, engineering, and technology. The Company offers a portfolio of Femtech solutions for breast health, breast aesthetics and breast reconstruction. The Motiva Flora® tissue expander is the only regulatory-approved expander in the world with an integrated port that is MRI conditional and is used to improve outcomes in breast reconstruction following breast cancer. Mia Femtech, Establishment Lab’s unique minimally invasive experience for breast harmony, is the Company’s most recent breakthrough innovation. These solutions are supported by over 200 patent applications in 25 separate patent families worldwide and over 50 scientific studies and publications in peer-reviewed journals.
Company Leadership



Alliage Global is a leading company in the medical and dental equipment sector, operating in over 150 countries with a strong presence in Latin America. The company focuses on research and development, offering innovative solutions through its brands such as Dabi Atlante, Saevo, and Gnatus. With a commitment to sustainability and quality, Alliage Global manufactures over 80% of its product components in-house, ensuring high standards and efficiency. Their target clients include dental professionals and healthcare providers seeking advanced and ergonomic equipment.
Company Leadership CB
AD
MM
Align Technology, founded in 1997, is a global medical device company that develops digital orthodontic and restorative dentistry solutions. They are best known for the Invisalign clear aligner system and iTero™ intraoral scanning technology, which help dental professionals improve treatment planning, patient care, and clinical outcomes. The company focuses on advancing digital dentistry through innovation, software, imaging, and customized treatment solutions that support dental practices and patients worldwide.
Company Leadership

DB
